Over $4.7 Million awarded in CIHR Project Grant funding over the next five years

The UBC Department of Medicine wishes to recognize and celebrate the outstanding achievements of the Fall 2018/Spring 2019 CIHR Project Grant recipients with funding totaling $4,720,658 over 3-5 years.

The CIHR Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects with a specific purpose and a defined endpoint. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches. Successful projects are aligned with the CIHR mandate: “To excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products, and a strengthened Canadian health care system”.

 

The Fall 2018/Spring 2019 Recipients from the UBC Department of Medicine are:

Dr. Antonio Avina-Zubieta (Rheumatology)
Risk of Retinal Toxicity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis on Long-term Hydroxychloroquine Therapy
Funding Amount: $707, 625 over 5 years

Dr. Liam Brunham and Dr. Simon Pimstone (General Internal Medicine)
Improving the identification and treatment of young adults with heart disease: the Study to Avoid cardioVascular Events in British Columbia (SAVE BC)
Funding Amount: $654,075 over 5 years

Dr. Edward Conway (Hematology)
Characterization of a novel cofactor for tissue factor (TF) that enhances its pro-thrombotic and pro-inflammatory activities.
Funding Amount: $826,200 over 5 years

Dr. Ryan McNeil and Dr. Jade Boyd (AIDS)
Housing and overdose risk environments: A community-based participatory research study
Funding Amount: $650,632 over 4 years

Dr. Katherine Plewes and Arjen Dondorp (Infectious Diseases)
Evaluating the renoprotective effect of acetaminophen in pediatric severe falciparum malaria: A randomized controlled trial.
Funding Amount: $971,551 over 3 years

Dr. Neil Reiner (Infectious Diseases)
Novel Mechanisms of Leishmania Pathogenesis
Funding Amount: $730,575 over 5 years

Dr. John Staples (General Internal Medicine)
Motor vehicle crash risk after cardioverter-defibrillator implantation: A population-based evaluation
Funding Amount: $180,000 over 3 years

Congratulations to all of the recipients!